Company page
Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. is a public company traded under the ticker XENE in the American market. With a market capitalization of approximately $5.11 billion, Xenon focuses on developing innovative therapies for neurological disorders. The company is committed to advancing its pipeline of drug candidates to address unmet medical needs.
- Ticker
- XENE:NASDAQ
- Asset type
- Stock
- Market cap
- $5.11B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD